Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2000 2
2001 2
2002 3
2003 2
2005 1
2006 4
2007 3
2008 1
2009 2
2010 1
2011 5
2012 6
2013 4
2014 9
2015 6
2016 5
2017 4
2018 3
2019 8
2020 9
2021 10
2022 11
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Subtyping monogenic disorders: Huntington disease.
Sturchio A, Duker AP, Muñoz-Sanjuan I, Espay AJ. Sturchio A, et al. Among authors: munoz sanjuan i. Handb Clin Neurol. 2023;193:171-184. doi: 10.1016/B978-0-323-85555-6.00003-5. Handb Clin Neurol. 2023. PMID: 36803810 Review.
Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease.
Khakh BS, Beaumont V, Cachope R, Munoz-Sanjuan I, Goldman SA, Grantyn R. Khakh BS, et al. Among authors: munoz sanjuan i. Trends Neurosci. 2017 Jul;40(7):422-437. doi: 10.1016/j.tins.2017.05.002. Epub 2017 May 31. Trends Neurosci. 2017. PMID: 28578789 Free PMC article. Review.
Moving toward a gene therapy for Huntington's disease.
Glorioso JC, Cohen JB, Carlisle DL, Munoz-Sanjuan I, Friedlander RM. Glorioso JC, et al. Among authors: munoz sanjuan i. Gene Ther. 2015 Dec;22(12):931-3. doi: 10.1038/gt.2015.102. Gene Ther. 2015. PMID: 26633828 No abstract available.
Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's Disease.
Liu L, Malagu K, Haughan AF, Khetarpal V, Stott AJ, Esmieu W, Vater HD, Webster SJ, Van de Poël AJ, Clissold C, Cosgrove B, Sutton B, Spencer JA, Breccia P, Gancia E, Bonomo S, Ladduwahetty T, Lazari O, Patel H, Atton HC, Clifton S, Mota DM, Magnani D, O'Neill A, Stebbeds M, Macabuag N, Todd D, Herva ME, Mitchell P, Visser M, Compte Sancerni S, Grand Moursel L, da Silva M, Kritikou E, Heikkinen TT, Bolkvadze T, Fodale V, Spadafora D, Daldin M, Bresciani A, Mangette JE, Doherty EM, Lee MR, Herbst T, Monteagudo E, Macdonald D, Plotnikov NV, Chambers M, McAllister G, Muňoz-Sanjuan I, Dominguez C. Liu L, et al. Among authors: munoz sanjuan i. J Med Chem. 2023 Sep 28;66(18):13205-13246. doi: 10.1021/acs.jmedchem.3c01173. Epub 2023 Sep 15. J Med Chem. 2023. PMID: 37712656
Therapeutic Strategies for Huntington's Disease.
Mrzljak L, Munoz-Sanjuan I. Mrzljak L, et al. Among authors: munoz sanjuan i. Curr Top Behav Neurosci. 2015;22:161-201. doi: 10.1007/7854_2013_250. Curr Top Behav Neurosci. 2015. PMID: 24277342 Review.
Modelling the Human Blood-Brain Barrier in Huntington Disease.
Vignone D, Gonzalez Paz O, Fini I, Cellucci A, Auciello G, Battista MR, Gloaguen I, Fortuni S, Cariulo C, Khetarpal V, Dominguez C, Muñoz-Sanjuán I, Di Marco A. Vignone D, et al. Among authors: munoz sanjuan i. Int J Mol Sci. 2022 Jul 15;23(14):7813. doi: 10.3390/ijms23147813. Int J Mol Sci. 2022. PMID: 35887162 Free PMC article.
102 results